John Savarino teaches ciLiving host, Jaclyn Friedlander about money related questions from the money tree. In this video, we answer money-related questions from the Money Tree, sparking meaningful ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Recursion Pharmaceuticals (RXRX) is drawing renewed attention after the appointment of Najat Khan as CEO and news of a narrowing net loss, both viewed as signals of improving execution. Investors also ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

Uses backtracking (DFS-style traversal) to explore all character arrangements from the input string. Tracks each recursion depth (tree level) and stores the generated paths. After recursion, it ...

GENEVA — Area residents kept arborist Alan Siewert busy with questions Saturday during Community Days at Memorial Field. Siewert was hired last year, through a federal grant, to help the city plan for ...